Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,938 | 407 | 98.7% |
| Education | $116.45 | 4 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $1,404 | 48 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $1,200 | 43 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $948.12 | 26 | $0 (2022) |
| Allergan, Inc. | $865.13 | 76 | $0 (2020) |
| Neurocrine Biosciences, Inc. | $777.88 | 18 | $0 (2022) |
| Lundbeck LLC | $683.99 | 51 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $514.90 | 19 | $0 (2023) |
| AbbVie Inc. | $478.74 | 26 | $0 (2023) |
| Vanda Pharmaceuticals Inc. | $254.29 | 13 | $0 (2022) |
| Shire North American Group Inc | $235.81 | 16 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $105.28 | 1 | Axsome Therapeutics, Inc. ($105.28) |
| 2023 | $248.57 | 3 | AbbVie Inc. ($112.00) |
| 2022 | $783.13 | 46 | ABBVIE INC. ($160.50) |
| 2021 | $306.73 | 13 | AbbVie Inc. ($206.24) |
| 2020 | $812.24 | 46 | Neurocrine Biosciences, Inc. ($153.97) |
| 2019 | $2,783 | 126 | Teva Pharmaceuticals USA, Inc. ($390.14) |
| 2018 | $2,124 | 98 | Otsuka America Pharmaceutical, Inc. ($446.15) |
| 2017 | $1,893 | 78 | Sunovion Pharmaceuticals Inc. ($482.17) |
All Payment Transactions
411 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/13/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $105.28 | General |
| Category: Psychology/Psychiatric | ||||||
| 05/31/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $112.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/16/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $77.65 | General |
| Category: PSYCHIATRY | ||||||
| 02/20/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $58.92 | General |
| Category: Neuroscience | ||||||
| 12/20/2022 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/16/2022 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: INSOMNIA | ||||||
| 12/14/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA, INVEGA | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Neuroscience | ||||||
| 12/12/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: PSYCHIATRY | ||||||
| 12/01/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Neuroscience | ||||||
| 11/22/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: PSYCHIATRY | ||||||
| 11/22/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $4.51 | General |
| Category: Central Nervous System | ||||||
| 11/22/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $3.44 | General |
| Category: Central Nervous System | ||||||
| 11/15/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: PSYCHIATRY | ||||||
| 11/10/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Neuropsychiatry | ||||||
| 11/09/2022 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/07/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: NEUROSCIENCE | ||||||
| 11/03/2022 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $29.18 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/03/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.46 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2022 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Central Nervous Stimulant ADHD | ||||||
| 10/26/2022 | Corium, LLC | AZSTARYS (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/26/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: PSYCHIATRY | ||||||
| 10/25/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Central Nervous System | ||||||
| 10/19/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: NEUROSCIENCE | ||||||
| 10/12/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 186 | 576 | $140,010 | $48,503 |
| 2022 | 4 | 283 | 707 | $159,745 | $54,222 |
| 2021 | 2 | 212 | 838 | $150,450 | $51,322 |
| 2020 | 5 | 378 | 922 | $177,276 | $49,723 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 127 | 447 | $109,515 | $38,143 | 34.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 48 | $16,320 | $5,904 | 36.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 63 | $11,025 | $3,561 | 32.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 15 | 18 | $3,150 | $894.37 | 28.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 123 | 392 | $96,040 | $35,299 | 36.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 130 | 242 | $42,350 | $11,415 | 27.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 52 | $17,680 | $6,589 | 37.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 14 | 21 | $3,675 | $917.69 | 25.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 193 | 819 | $143,325 | $48,847 | 34.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 19 | 19 | $7,125 | $2,475 | 34.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 172 | 567 | $99,225 | $27,691 | 27.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 98 | 194 | $47,530 | $13,593 | 28.6% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 59 | 101 | $17,675 | $4,934 | 27.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 31 | 32 | $12,000 | $3,407 | 28.4% |
| 96127 | Brief emotional or behavioral assessment | Office | 2020 | 18 | 28 | $846.00 | $98.56 | 11.7% |
About Dr. Getulio Tovar, M.D
Dr. Getulio Tovar, M.D is a Psychiatry healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053374082.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Getulio Tovar, M.D has received a total of $9,055 in payments from pharmaceutical and medical device companies, with $105.28 received in 2024. These payments were reported across 411 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($8,938).
As a Medicare-enrolled provider, Tovar has provided services to 1,059 Medicare beneficiaries, totaling 3,043 services with total Medicare billing of $203,769. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Lexington, KY
- Active Since 04/10/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1053374082
Products in Payments
- VRAYLAR (Drug) $1,332
- REXULTI (Drug) $1,289
- LATUDA (Drug) $1,200
- INGREZZA (Drug) $777.88
- AUSTEDO (Drug) $754.58
- SPRAVATO (Drug) $369.45
- ABILIFY MAINTENA (Drug) $299.67
- TRINTELLIX (Drug) $222.11
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $173.53
- Trintellix (Drug) $172.41
- NUPLAZID (Drug) $158.58
- MYDAYIS (Drug) $157.86
- Fanapt (Drug) $147.28
- INVEGA SUSTENNA (Drug) $145.45
- Auvelity (Drug) $141.72
- Adzenys XR-ODT (Drug) $127.10
- VYVANSE (Drug) $105.08
- LYBALVI (Drug) $100.49
- BRINTELLIX (Drug) $98.34
- SD809-TD (Drug) $94.31
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Lexington
Mark Wright, M.d, M.D
Psychiatry — Payments: $619,046
Dr. Steven Croley, Md, MD
Psychiatry — Payments: $111,876
Syed Rizvi, M.d, M.D
Psychiatry — Payments: $17,719
Dr. Paolo Cassano, Md, Phd, MD, PHD
Psychiatry — Payments: $12,649
Kathleen Lundvall, Md, MD
Psychiatry — Payments: $9,100
Mr. Saeed Hamid, M.d, M.D
Psychiatry — Payments: $8,148